MarketPulse
N

$NKTR

22 articles found
1 positive
21 negative
0 neutral
BenzingaBenzinga··Djs Law Group

Nektar Therapeutics Faces Class Action Lawsuit Over Misleading REZOLVE-AA Study Claims

Nektar Therapeutics ($NKTR) faces class action lawsuit alleging false statements about REZOLVE-AA trial protocol adherence, threatening regulatory approval timelines and shareholder value.
NKTRclass action lawsuitfalse statements
BenzingaBenzinga··Business Wire

Nektar Therapeutics Faces Securities Fraud Lawsuit Over Misleading Trial Claims

Schall Law Firm seeks investors in class action against $NKTR over alleged false statements regarding REZOLVE-AA trial enrollment and integrity.
NKTRsecurities fraudclass action lawsuit